gc012f
gracell biotechnologies
['hodgkin', 'gc012f ', 'lymphoma', '$grcl', 'gracell']
gracell biotechnologies ( $grcl)
$4.60 +0.60 (+15%)
#longtermsk presents longer-term results for fastcar-t gc012f in b-cell non-hodgkin s lymphoma at eha2023, highlighting 100% overall response rate treatment of cancer &amp; autoimmune disease 
Stefan Katafai
 President@Agent4Stars.com
 +34 637 97 37 42
 https://t.co/B9Lu0tMAIX